Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting
FREDERICK, Md., Nov. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that ...